This blog was prepared and written by PLOS One Associate Editor Alejandro Torrado Pacheco. Since its inception in 2008, Rare Disease Day is observed… Since its inception in 2008, Rare Disease Day is observed annually with the objective to build community, drive advocacy efforts, and raise awareness of the challenges that people with rare diseases face. Despite the diversity in geography and clinical presentation, people living with rare diseases face universal challenges. On average, patients wait 5 years or more to receive a diagnosis, while facing much higher medical costs than people with non-rare conditions. Miriam Hickey: One issue with rare diseases is that it typically takes much longer for patients to obtain a diagnosis, or they may remain undiagnosed. This can be due to a number of reasons but can sometimes be caused by a lack of awareness or the need for many specialists to reach a diagnosis. This places a burden on patients, their families and their communities, and delays accurate treatment. We work with accurate models of rare disease to improve understanding of symptoms and pathology, as well as the underlying pathophysiology. By increasing knowledge of symptoms, pathology and their progression, we hope to support earlier recognition and diagnosis of the disease.

Original title: “Rare Disease Day 2026: Diverse community, common challenges - EveryONE”

What a way to head into the final days of Rare Disease Week 2026! Despite a little drizzle and some gray clouds, hundreds of rare disease advocates participated in more than 300 Hill visits on Thursday to share their stories and advocate for rare disease policies.   […] The post Rare Disease Week 2026: Senate Hearing Recap appeared first on EveryLife Foundation for Rare Diseases.

Original title: “Rare Disease Week 2026: Senate Hearing Recap”

Rare Disease Day reminds us that rare conditions impact far more lives than many realize -over 300 million people globally, across more than 10,000 identified rare diseases. Yet what strikes me most on this day of recognition and reflection is that listening to patients remains an under-utilized ... Every year, Rare Disease Day reminds us that rare conditions impact far more lives than many realize -over 300 million people globally, across more than 10,000 identified rare diseases. Yet what strikes me most on this day of recognition and reflection is that listening to patients remains an under-utilized lever for achieving progress in healthcare. At Ipsen, we are committed to integrating the patient’s voice from discovery through lifelong care. But this is a shared responsibility across the entire ecosystem. So, if we truly want to help people living with rare diseases achieve more than you can imagine, the Rare Disease Day annual theme, listening to patients cannot be a value-based aspiration. Listening means understanding the whole person, not just their biology. Rare diseases disrupt education, employment, mental health, and family life. Economic analyses consistently show that the greatest burden is carried by families—through lost income, caregiving, and out-of-pocket costs.

Original title: “Rare Disease Day 2026, Listening isn’t a slogan”

Veronica Chiavaroli, one of the event’s organizers and a parent of a child with a rare genetic condition, brought both urgency and warmth to the gathering. Introducing the speakers, she emphasized the importance of community partnerships and the collaboration between families, researchers ... Veronica Chiavaroli, one of the event’s organizers and a parent of a child with a rare genetic condition, brought both urgency and warmth to the gathering. Introducing the speakers, she emphasized the importance of community partnerships and the collaboration between families, researchers and civic leaders. Regulatory designations such as orphan disease and rare pediatric fast track status have shifted what is possible, he said, though funding and public awareness remain critical challenges. Kendrick Luse, a portfolio manager at Point72 where he focuses on investments in emerging Biotech and Medical Devices, echoed the need for continued advocacy. Greenwich and Connecticut based rare disease foundations including the Golden Lights Foundation, Dana’s Angels Research Trust, Hopper-Belmont Foundation, Fibrolamellar Cancer Foundation, National Organization of Rare Disorders Rare Cancer Coalition, Connecticut Rare Action Network, Defeat Adult Refsum Everywhere, Sarcoma Alliance for Research through Collaboration and others have taken a leadership role in raising awareness for rare diseases. Explaining how one person can spark a movement, as this act started the initial waves of research into rare diseases. Feb 26, 2026. Photo: James Bonney · Later, Dr. Martha Martin, whom Chiavaroli credited with “fully saving my child’s life,” shared lessons from years of caring for families facing rare diagnoses. “Every medical breakthrough starts with a single patient and their family,” she said, recounting the story of a mother in 1885 who sought out Louis Pasteur to save her son from rabies.

Original title: “Rare Disease Day in Greenwich Puts Families, Hope and Research at the Center | Greenwich Free Press”

Columnist Lara Govendo shares her thoughts about Rare Disease Day, and how living with cystic fibrosis shapes her advocacy. Despite days being set aside to observe them, a lack of awareness about rare diseases remains. There is less research, funding, and advocacy. Still, I’m so rare that my own gene mutations are among the 10% of the CF population for which modulators do not help. I won’t go into how disheartening it is to see others living relatively normal lives while a small group of us watch on the sidelines. Just know that we’re still out here, waiting on our miracle drug. ... Some diseases remain at the forefront of our minds because they affect many people. Through ad campaigns, celebrity endorsements, and corporate support, these diseases take center stage and receive more funding for research, clinical trials, and support groups. I don’t mean to suggest that getting more attention diminishes their seriousness. It’s not a competition. No disease should be celebrated. But Rare Disease Day asks us to focus on disease communities that don’t often get much attention. I didn’t know much about other rare disease communities until I connected with them. It’s impossible to have the bandwidth to know about everything. That’s totally valid, and I feel that on a soul level. For that reason, I’m grateful, ultimately, that days like Rare Disease Day exist.

Original title: “While living with cystic fibrosis, every day is Rare Disease Day for me”

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development challenges. This was spurred by activists who lobbied Congress to take action against the drought of therapies for several rare diseases like Huntington’s disease, amyotrophic lateral sclerosis (ALS), Tourette syndrome, and muscular dystrophy. Thus, the National Organization for Rare Disorders (NORD) was formed to unite patient advocacy groups and raise awareness of rare diseases. Much of this is owed to regulatory and manufacturing hurdles that drug developers face. As people who have rare diseases belong to small patient populations, traditional clinical trial designs are “poorly suited” for rare diseases, according to Matthew Wood, professor of Neuroscience at the University of Oxford. According to the BioIndustry Association: “Developing any drug is a long and expensive process, but for rare diseases, the situation is even more difficult. Smaller patient populations make research more challenging, and the opportunity to get a return on investment smaller.” Wood expressed that there exists a “translational gap” when it comes to research and development (R&D) in the rare disease space. “World-class science exists, but (there is) insufficient infrastructure to move discoveries into drug development. OHC was established to help close that gap,” said Wood. Despite the incentives that accompanied the Orphan Drug Act, many argue that they are insufficient to meet the urgent unmet needs of patients while driving high costs.

Original title: “Rare Disease Day: is a regulatory overhaul what the therapeutic field needs?”

PARAMUS, NJ, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel,... The National Organization for Rare Diseases (NORD), a rare disease patient advocacy organization, notes that a disease is considered rare when it affects fewer than 1 in 2,000 people globally, with approximately 70% of these diseases starting in childhood. There are more than 6,000 rare diseases identified, 72% of which are genetically inherited. “On Rare Disease Day, Polaryx proudly stands alongside the rare disease community - patients, families, caregivers, researchers, and advocacy partners to underscore the urgent need for new and transformative treatments,” said Alex Yang, Chairman and Chief Executive Officer of Polaryx Therapeutics, Inc. For more information about Rare Disease Day, please visit www.rarediseaseday.org. ... SOTERIA is a Phase 2, open-label, single arm trial intended to assess the safety, tolerability, and clinical activity of Polaryx’s lead drug candidate, PLX-200, in CLN2, CLN3, Krabbe disease, and Sandhoff disease, four different LSDs whose patient populations Polaryx believes represent approximately one quarter of the LSD population. A natural history study is a preplanned observational study intended to track the course of the disease. Should the data demonstrate compelling clinical activity, Polaryx may seek conditional marketing authorization. ... Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing patient-friendly small molecule and gene therapy treatments for rare orphan lysosomal storage disorders (LSDs).

Original title: “Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders”

Rare Disease Day 2026 will be observed with a special theme raising global awareness about over 6,000 rare diseases and highlighting the urgent need for early diagnosis, equitable healthcare access, research and support for patients and families worldwide. Since its creation in 2008, Rare Disease Day has played a crucial role in building an international rare disease community. It was established and is coordinated by EURORDIS in partnership with over 70 national alliance patient organisations. The day serves as a powerful focal point, driving advocacy efforts at local, national, and international levels. This global event aims to raise awareness about rare diseases and the challenges faced by patients and their families. Rare Disease Day also serves as an opportunity to highlight the urgent need for equitable access to diagnosis for patients, the required treatment, healthcare and overall support. A disease is typically classified as rare when it affects a small percentage of the population, yet collectively, rare diseases impact millions of people worldwide. Many of these conditions are genetic, chronic, progressive, and can be life-threatening. Hence, early detection and research for such diseases are important. According to the official Rare Disease Day website, over 6,000 rare diseases are characterised by a wide range of conditions and symptoms that can vary not only between diseases but also among individuals with the same condition.

Original title: “Rare Disease Day 2026: Date, Theme, History and Significance of the Global Health Awareness Day”

On 28 February 2026, Rare Disease Day will once again bring together millions of people worldwide to spotlight the realities faced by those living with rare diseases and… Continue reading Rare Disease Day 2026 highlights global inequities and amplifies youth voices in call for lasting change In the lead-up to Rare Disease Day 2026, the campaign placed particular emphasis on youth leadership in global advocacy. Rare Disease Day exists to address these inequities. Since its launch in 2008, when events were held in just 18 countries, the campaign has grown into a global movement now observed in more than 100 countries. Coordinated by national alliances and patient organisations across 77 countries, it creates a shared moment each year to make visible challenges that often remain overlooked in health and social care systems, and policy debates. Maksym, Youth Regional Representative for Europe, described the shift that youth leadership can create, outlining work “created by and for young people with rare diseases, where lived experience is turned into leadership, advocacy, and concrete action.” On 28 February 2026, Rare Disease Day will once again bring together millions of people worldwide to spotlight the realities faced by those living with rare diseases and to call for more equitable healthcare, research and social inclusion.

Original title: “Rare Disease Day 2026 highlights global inequities and amplifies youth voices in call for lasting change - Rare Disease Day 2026”

On 28 February 2026, Rare Disease Day will once again bring together millions of people worldwide to spotlight the realities faced by those living with rare diseases and… Continue reading Rare Disease Day 2026 highlights global inequities and amplifies youth voices in call for lasting change In the lead-up to Rare Disease Day 2026, the campaign placed particular emphasis on youth leadership in global advocacy. Rare Disease Day exists to address these inequities. Since its launch in 2008, when events were held in just 18 countries, the campaign has grown into a global movement now observed in more than 100 countries. Coordinated by national alliances and patient organisations across 77 countries, it creates a shared moment each year to make visible challenges that often remain overlooked in health and social care systems, and policy debates. Maksym, Youth Regional Representative for Europe, described the shift that youth leadership can create, outlining work “created by and for young people with rare diseases, where lived experience is turned into leadership, advocacy, and concrete action.” On 28 February 2026, Rare Disease Day will once again bring together millions of people worldwide to spotlight the realities faced by those living with rare diseases and to call for more equitable healthcare, research and social inclusion.

Original title: “Rare Disease Day 2026 highlights global inequities and amplifies youth voices in call for lasting change - Rare Disease Day 2026”

Join the global call to action on World Rare Disease Day as we strive for a brighter future for the 300 million people living with rare diseases. Discover how public-private partnerships and digital innovations are transforming diagnosis and care in the Middle East and Africa, ensuring faster ... Join the global call to action on World Rare Disease Day as we strive for a brighter future for the 300 million people living with rare diseases. Discover how public-private partnerships and digital innovations are transforming diagnosis and care in the Middle East and Africa, ensuring faster diagnoses, localised expertise, and equitable access to treatments. It was a turning point that shifted rare diseases from an overlooked concern to a global health priority. In the Middle East and Africa, public-private partnerships and digital innovations are shrinking diagnostic journeys and bringing world-class care closer to home. To ensure this translates into real change for patients in our region, we must now focus our efforts on three critical areas. First, we must diagnose these diseases earlier and faster. Adoption of digital tools that support clinical decisions is key, and a shift currently being driven by innovative regional collaborations. One of these partnerships is integrating AI technologies to accelerate the diagnosis of a rare disorder across the Middle East and Africa, while reducing the risk of misdiagnosis and its consequences, helping patients access appropriate care in less time. By transferring knowledge and concentrating resources within countries, these hubs enable patients to receive the care they need close to home, without having to travel long distances or go to other countries, which creates a significant burden that many patients find difficult to bear. Finally, prioritising equitable access is essential, so that medical innovations are available to everyone. Given 70 per cent of rare diseases present in childhood, universal newborn screening is a critical way for health authorities to enable early disease diagnosis, even before symptom onset.

Original title: “World Rare Disease Day: Advancing Diagnosis and Care for 300 Million Patients”

It's not just about awareness but also a call to action for patients, families, employers, payers and policymakers to modernize the systems that shape It’s not just about awareness but also a call to action for patients, families, employers, payers and policymakers to modernize the systems that shape access to care. It must focus on connecting innovation with the infrastructure that governs approval, coverage and affordability. Rare Disease Day began in 2008, launched in Europe by EURORDIS to shine a light on millions living with conditions that were often misunderstood, misdiagnosed or ignored.

Original title: “Rare Disease Day 2026: From Awareness to Access in a Volatile Year for Patients and Specialized Therapies – RamaOnHealthcare”

This report describes a 2024 Salmonella outbreak linked to ice in a cooler at a county fair in Illinois.

Original title: “Multicounty Outbreak of Salmonella Agbeni Linked to Ice in a Cooler at a County Fair — Illinois, August 2024”

Rare Disease Day is a reminder that behind every protocol number is a person. A family. A timeline that feels urgent. In rare disease research, there are no redundant trials. There are no “we’ll fix it next time” opportunities. Many studies involve small patient populations, global site ... Rare Disease Day is a reminder that behind every protocol number is a person. A family. A timeline that feels urgent. In rare disease research, there are no redundant trials. There are no “we’ll fix it next time” opportunities. Many studies involve small patient populations, global site distribution, accelerated pathways, and heightened regulatory attention. Smaller studies do not mean simpler oversight. In fact, rare disease trials often demand stronger collaboration between sponsors, CROs, clinical operations, regulatory teams, and clinical supplies. Global sites may be activated quickly. Compassionate use programs may overlap. In rare disease trials, they are operational safeguards. SOP mapping exercises, real world scenarios, and metrics discussions are not academic exercises. They are preparation for high visibility, high impact research. Rare disease research demands precision. It demands alignment. It demands documentation that tells a clear and confident story. On Rare Disease Day, we recognize the patients and families who place their trust in clinical research. And that includes the Trial Master File. In rare disease trials, the TMF is not just a regulatory requirement. It is the documented story of how carefully and ethically the study was conducted.

Original title: “Rare Disease Day: Why Every Document Matters More - LMK Clinical Research, LLC”

“Nearly 2 million video views ... of the patients and families who chose to share their experiences. Individuals who had previously lived in silence with their suffering at the hands of this disease now have a platform to share their stories, connect with one another, and help bring greater understanding of Netherton Syndrome to the broader medical and advocacy communities. That expanded awareness is exactly what this campaign was meant to create.” · In conjunction with Rare Disease Day, ... “Nearly 2 million video views and more than 24 million impressions later, what stands out most is the courage of the patients and families who chose to share their experiences. Individuals who had previously lived in silence with their suffering at the hands of this disease now have a platform to share their stories, connect with one another, and help bring greater understanding of Netherton Syndrome to the broader medical and advocacy communities. That expanded awareness is exactly what this campaign was meant to create.” · In conjunction with Rare Disease Day, the campaign recently released its latest video, “If There Was a Cure,” featuring patients and families reflecting on what meaningful treatment progress would mean in their lives. Through patient and caregiver stories, clinical perspectives and educational content, Quoin’s NETHERTON NOW awareness campaign has generated nearly 2 million video views and more than 24 million impressions globally, reflecting the positive impact of the campaign’s message to grow awareness of this long-neglected disease. “When we launched NETHERTON NOW at the beginning of Rare Disease Month last year, we hoped it would resonate, but the response has far surpassed anything we anticipated,” said Denise Carter, Co-Founder and Chief Operating Officer of Quoin Pharmaceuticals. Quoin’s lead investigational candidate, QRX003, is currently being evaluated in late-stage pivotal clinical trials for the treatment of Netherton Syndrome. The Company remains committed to addressing the significant unmet medical needs faced by patients and families impacted by this devastating disease. For more information about Rare Disease Day, visit www.rarediseaseday.org. Quoin Pharmaceuticals Ltd. is a late clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams.

Original title: “NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome - BioSpace”

Tarik lived with a rare germ cell tumor and the resulting hypopituitarism. Even with all the challenges, he found ways to laugh, to love, and… Continue reading Rare, but Never alone I share his story today to bring visibility to rare diseases and the families behind them.

Original title: “Rare, but Never alone - Rare Disease Day 2026”

by Claire Blake and Annika Paulsen – UNMC Genetic Counseling Class of 2026 What is Rare Disease Day?Rare Disease Day takes place on the last day of February, falling on February 28th this year but 29th in a leap year. The 29th of February only happens every 4 years and is the rarest day on […] References Admin, G. (2025, June 2). What is the “Diagnostic Odyssey” And how do we end it? GeneDx®. Home. (n.d.). Retrieved February 12, 2026 Homepage. (n.d.). Rare Disease Day 2026. Retrieved February 12, 2026. Join the Rare Action Network® | Advocacy for Rare Diseases. History of Rare Disease Day The first Rare Disease Day was celebrated in 2008 with 18 countries participating. North American patient organizations joined the celebration in 2009. There are now thousands of events that occur on every continent in the month of February. What is Rare Disease Day? Rare Disease Day takes place on the last day of February, falling on February 28th this year but 29th in a leap year. The 29th of February only happens every 4 years and is the rarest day on the calendar. The primary goal is to increase the awareness of rare disease among law- and other decision-makers as well as the general public. What is a rare disease? A rare disease is one in which fewer than 1 in 2,000 people have the diagnosis. Rare diseases may be missed because common symptoms may overlap with those of a rare disease. This can make it difficult to diagnose and may delay access to necessary care, a journey called a diagnostic odyssey.

Original title: “Rare Disease Day 2026: Show Your Stripes and Raise Awareness - Allied Health Blog | Allied Health Blog | University of Nebraska Medical Center”

Every year on the last day of February, the world turns its gaze toward a community that is often invisible, yet 300 million strong. February 28, 2026, marks the 19th annual Rare Disease Day. February 28, 2026, marks the 19th annual Rare Disease Day, and this year's theme, "More Than You Can Imagine," is a powerful reminder that while a single disease may be rare, the collective experience of living with one is a global reality. The spotlight in 2026 falls on equity, ensuring that the exhausting "diagnostic odyssey" so many patients endure ends sooner, and that life-saving treatments aren't determined by where you live or what you earn. The UK's Rare Diseases Framework has been extended through 2027, providing a vital bridge for policy and funding. Across Europe, the ERDERA (European Rare Diseases Research Alliance) has launched major transnational research initiatives, using AI and multi-omics to solve previously undiagnosed cases. Equity doesn't mean treating everyone the same, it means giving everyone what they need to thrive. As Rhiannon Walls, Rare Disease Day Global Lead, puts it: "Recognition is only the first step. For further information about Rare Disease Day 2026, please visit

Original title: “More Than You Can Imagine: Rare Disease Day 2026”

Nedirim is advancing rights and raising awareness for rare syndromes. Nedirim, a non-profit organization founded by parents of children born with these rare and serious disorders, assists parents and families in dealing with the difficulties that they face, acting as a support network for 1,800 familes in Israel. Dealing with illness is difficult in any circumstance, and even more so when the disease is rare and largely unrecognized. Dana Goldstein, who founded Nedirim in 2020 together with Natali Gespan Shpigner and Itai Weiss, explains that the organization is built on the belief that parents should not have to face these challenges alone. “One of the most difficult moments is when you receive a diagnosis of a rare disease, and you have no one to turn to. To mark Rare Disease Day this February 28 and raise awareness for millions of people worldwide living with a rare disease, Nedirim has embarked on a fundraising campaing to enable it to provide additional services to the parents, children, and families which it serves, including providing augmentative and alternative communication methods (AAC) – tools and strategies that help parents and children with these diseases communicate when speech is difficult or not possible, recreational days for children and activities, and additional support groups throughout the country. In Israel, approximately 50,000 children live with rare genetic diseases and syndromes, and thousands more are diagnosed each year.

Original title: “Rare Disease Day: “We are here for them, but they need you to be here for them as well"”

While you should never rely solely on AI tools when applying for jobs, they can greatly benefit the application process. Recruiting expert Bryan Blair discusses how using large language models can set you apart from the competition and includes a prompt framework to get you started.

Original title: “AI Tips and Prompts That Can Take Your Job Search to the Next Level”